How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

General Infectious Disease Archives

Login / Signup

Technology Demonstrates Ability to Transform Influenza Vaccines Into Universal Formulations

Lowest Weekly Increase Since January

Understanding the Syndemic Interplay Between Noncommunicable Chronic Diseases and Multidrug Resistant Infections

Persistent SARS-CoV-2 Infection Lasting Over 750 Days Documented in Person With HIV

Are There Benefits to Combination Therapy for Drug-Resistant Pseudomonas Infections?

CDC Links Salmonella Outbreak to Metabolic Meals Home Delivery Products

Immortalized B-Cell Libraries Could Lead to Therapeutic Development Against Evolving Viral Threats

FDA Clears Human Challenge Trial for First Potential Norovirus Antiviral, CDI-988

Why the flu turns deadly for older adults, and how scientists found the cause

Implementation Science Builds Partnerships to Create Better Access to Healthcare

Schedule an Appointment

Quick Links

Patient Forms

Contact Us